MC10 and Gait Impairment

Arthur Combs, MD is a physician executive and serial entrepreneur. After more than 20 years in clinical practice Art has spent the last 20 years bringing new medical technologies to market, as an officer of 5 successful start-up companies and a Fortune 500 senior executive. His focus has been on non-invasive technologies, although he has consulted across the life science spectrum from pharma to biotech, proteomics, molecular diagnostics and medical devices. Art is currently the CMO of MC10 Inc. an entrepreneurial company positioned to revolutionize clinical trials and chronic disease management through wearable technology. MC10’s technology is capable of gathering physiological and biometric data on ambulatory subjects in the home, and other non-clinical environments, as well as aiding researchers in the laboratory. The opportunities are many – longitudinal data from the home setting, transforming the clinical trials paradigm, chronic disease management, evolving subjective evaluations into objective assessments and the identification of meaningful digital biomarkers and clinical endpoints. Dr. Combs was instrumental in overseeing the company’s pivotal clinical trial and successful 510(k) application. The clinical unmet need, an elegant technological solution and a cogent business model guide Art’s entrepreneurial model for success. Dr. Combs is holder of 2 honorary fellowships, inventor on 2 U.S. patents, and author of numerous original scientific articles, abstracts, editorials and book chapters.